Västra Hamnen Corp. Finance
Bioextrax: Sweet dreams of a bright 2024
- Joint Development Agreement with the candy producer in Q1
- Progression in several projects, funding risk remains
- Our model implies a fair valuation of SEK 7.60 per share
A quiet final quarter of 2023 was followed by an eventful start of 2024 for Lund-based Bioextrax. In January, the American startup terminated the contract due to financial issues. For Bioextrax, the financial impact of the cancellation was limited according in our valuation model. However, the stock market reaction on the news was harsh sending the share price down by 30 per cent.
The initial research report is available here.
| Datum | 2024-02-16, kl 19:00 |
| Källa | MFN |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!